课题基金 / 基金详情

项目摘要

项目成果

Victoria Perepelitsa Belancio的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The goal of this proposal is to understand the mechanistic aspects of cellular responses to L1 activity, to evaluate L1 -induced mutagenesis and its contribution to DNA damage and associated aging, to determine whether this contribution increases with age, and to find out potential variation of this contribution among individuals. These goals are important because the existing data indicate that the DNA damage in the form of double-strand breaks (DSBs) inflicted by the L1-encoded DNA endonuclease is potentially much greater than the insult to the genome caused by the element via insertional mutagenesis. We detected endogenous L1 expression in a number of somatic cells. Therefore this type of DNA damage has consequences for the whole organism, not only for its progeny. We also wish to address the L1 contribution to the DNA damage and associated aging in human stem cells. For these studies we will manipulate L1 expression levels and correlate L1 activity with the resulting DNA damage by western blot analysis, g-H2AX foci staining, and COMET assays in normal cell lines. We will use reporter assay to quantify the mutagenic potential of L1 elements. We will use cultured primary cell models to determine L1 potential to accelerate cellular senescence in somatic and stem cells. Reported ability of L1 elements to inflict DNA damage and its endogenous expression in a number of human tissues fundamentally changes our understanding of the significance of the L1 expression and its impact on the health of the host. This project is designed to determine whether ongoing low levels of L1 expression in somatic and stem cells lead to a steady accumulation of mutations due to the error-prone repair of the DSBs created by the L1 endonuclease. The direct health implication of this discovery would be L1 contribution to mammalian aging and/or age- associated diseases such as cancer. Due to the constant improvement of the health care there is a growing population of older people that is more susceptible to age-associated diseases. Understanding of the molecular mechanisms of aging would contribute to our potential to prevent the onset of aging or age- associated diseases.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Characterization of L1 ORF1p self-interaction and cellular localization using a mammalian two-hybrid system.
使用哺乳动物双杂交系统表征 L1 ORF1p 自相互作用和细胞定位。
DOI: 10.1371/journal.pone.0082021
发表时间: 2013
期刊: PloS one
影响因子: 3.7
作者: [Sokolowski,Mark, deHaro,Dawn, Christian,ClaiborneM, Kines,KristineJ, Belancio,VictoriaP]
通讯作者: Belancio,VictoriaP
DOI: 10.1093/nar/gku503
发表时间: 2014-07
期刊: Nucleic acids research
影响因子: 14.9
作者: [deHaro D, Kines KJ, Sokolowski M, Dauchy RT, Streva VA, Hill SM, Hanifin JP, Brainard GC, Blask DE, Belancio VP]
通讯作者: Belancio VP
Feedback inhibition of L1 and alu retrotransposition through altered double strand break repair kinetics.
通过改变双链断裂修复动力学反馈抑制 L1 和 alu 逆转座。
DOI: 10.1186/1759-8753-1-22
发表时间: 2010
期刊: Mobile DNA
影响因子: 4.9
作者: [Wallace,NicholasA, Belancio,VictoriaP, Faber,Zach, Deininger,Prescott]
通讯作者: Deininger,Prescott
Polymorphic L1 transposons as a Genetic Variable Distinguishing Aggressive from Indolent Prostate Cancer
Pilot Projects Program
  • 批准号:
    10631210
  • 项目类别:
  • 资助金额:
    $23.1万
  • 财政年份:
    2022
  • 负责人:
    Victoria Perepelitsa Belancio
  • 依托单位:
Pilot Projects Program
  • 批准号:
    10414533
  • 项目类别:
  • 资助金额:
    $23.1万
  • 财政年份:
    2022
  • 负责人:
    Victoria Perepelitsa Belancio
  • 依托单位:
FASEB's Mobile DNA: Evolution, Diversity, and Impact Conference.
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: